Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Management of agitation and aggression associated with Alzheimers disease: controversies and possible solutions
Current Opinion in Psychiatry, 10/12/09
Ballard C et al. – Large prospective, randomized, placebo–controlled trials are needed to establish the role of agents other than neuroleptics as clinical therapies for the treatment of BPSD and studies are urgently needed to evaluate BPSD treatments in non–Alzheimer dementias.
Related Articles
Does Diabetes Speed Up Memory Loss In Alzheimers Disease?
ScienceDaily, 10/28/09
Relevance Score: 71%
High Blood Pressure Likely in Alzheimers Offspring
MedLinePlus, 11/04/09
Relevance Score: 70%
Protective Role For Copper In Alzheimers Disease
ScienceDaily, 10/14/09
Relevance Score: 69%
The Antiapoptotic Activity of Melatonin in Neurodegenerative Diseases
CNS Neuroscience & Therapeutics, 11/11/09
Relevance Score: 68%
Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
Neuropsychiatric Disease and Treatment, 11/04/09
Relevance Score: 68%
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Association of the Glutamate Transporter Gene SLC1A1 With Atypical Antipsychotics-Induced Obsessive-compulsive Symptoms
Archives of General Psychiatry, 11/20/09
Stability of symptoms across major depressive episodes in bipolar disorder
Bipolar Disorders, 11/20/09
Sequential Combined Treatment of Heroin Addicted Patients in Portugal with Naltrexone and Family Therapy
European Addiction Research, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


